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BACKGROUND. Gallbladder cancer (GBC) is rare; however, it disproportionately
affects the American Indian and Alaska Natives (AI/AN) population. The purpose
of the study was to characterize GBC among AI/AN in the US population.
METHODS. Cases of GBC diagnosed between 1999 and 2004 and collected by
state-based cancer registries were included. Registry records were linked with
Indian Health Service (IHS) administration records to decrease race misclassi-
fication of AI/AN. GBC rates and/or percent distributions for AI/AN and non-His-
panic whites (NHW) were calculated by sex, IHS region, age, and stage for all US
counties and IHS Contract Health Service Delivery Area (CHSDA) counties, in
which approximately 56% of US AI/AN individuals reside.
RESULTS. In CHSDA counties, the GBC incidence rate among AI/AN was 3.3 per
100,000, which was significantly higher than that among NHW (P < .05). Rates
varied widely among IHS regions and ranged from 1.5 in the East to 5.5 in
Alaska. Rates were higher among AI/AN females than males in all regions, except
the Northern Plains. Higher percentages of GBC were diagnosed among AI/AN
aged <65 years compared with NHW. GBC was most often diagnosed at the re-
gional stage among AI/AN, whereas GBC was most often diagnosed at regional or
distant stages among NHW.
CONCLUSIONS. To the authors’ knowledge to date, this is the most comprehensive
study of GBC incidence among AI/AN in the US. The accurate characterization of
GBC in this population could help inform the development of interventions
aimed at reducing morbidity and mortality from this disease. Cancer 2008;113(5
suppl):1266–73. Published 2008 by the American Cancer Society.*
KEYWORDS: American Indian/Alaska Native, surveillance, gallbladder cancer,
regional stage, distant stage.
G allbladder cancer (GBC) is an uncommon but highly fatal malig-nancy; a little over 3200 cases of GBC were diagnosed in the US
in 2004.1 Signs and symptoms of GBC, such as abdominal pain, are
often vague. In many cases, GBC is found incidentally at the time of
evaluation and surgical management for gallstones.2 The lack of
specific symptoms leads to frequent diagnosis at advanced stages of
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disease, when treatment options are limited. The
overall median survival for advanced stage GBC is
2 months to 5 months.3
Because of the rarity of GBC, few studies have
examined its burden in the US population. Recent
studies using data from population-based cancer
registries suggest that GBC incidence rates are rela-
tively high among American Indian/Alaska Native
(AI/AN) populations compared with other racial and
ethnic populations,4–6 with AI/AN individuals in New
Mexico having the highest GBC incidence rates in
the US.6
The AI/AN population in the US accounts for
approximately 1% of the total population,1 and can-
cer registries are known to under–report AI/AN race.
A linkage study of registry data from the National
Cancer Institute’s Surveillance, Epidemiology, and
End Results (SEER) program with the National Longi-
tudinal Mortality Study (NLMS) data (a source of
self-reported demographic data) concluded that AI/
AN were considerably under–reported in SEER data
by 66%, which was mainly because of SEER registries
misclassifying AI/AN persons as white.7
The objective of the current study was to extend
the work of previous studies that have reported a dis-
proportionate burden of GBC in AI/AN populations
by providing a more accurate description of GBC
incidence among AI/AN. We describe GBC incidence
for the US using the most geographically compre-
hensive population-based cancer registry data avail-
able, collected by the Centers for Disease Control
and Prevention’s National Program of Cancer Regis-
tries (NPCR) and the SEER program. NPCR and SEER
registry data in this report are further enhanced
through linkage with the Indian Health Service (IHS)
patient registration database to reduce race misclas-
sification of AI/AN. This study is part of a larger
effort whose aim is to provide a more accurate
description of cancer incidence among AI/AN.
MATERIALS AND METHODS
Detailed descriptions of the data sources and meth-
ods used for this analysis are found in another article
in this supplement.8
Cases of GBC diagnosed between 1999 and 2004
were collected by cancer registries affiliated with the
NPCR or SEER programs. GBC cases were defined
according to the International Classification of Dis-
eases for Oncology, third edition (C23.9)9; only inva-
sive cases of GBC were included in analyses. Some
histologies (lymphomas originating in the gallblad-
der, histologies involving hematopoietic diseases,
mesotheliomas, and Kaposi sarcomas [M9050-9055,
9140, and 9590-9989]) were excluded.9 Cases of GBC
were included only from those states that met high–
quality data criteria for publication.1,8
To reduce the misclassification of AI/AN race, all
case records from each registry were linked with the
IHS patient registration database to identify AI/AN
cases misclassified as another race. The IHS provides
medical services to AI/AN who are members of fed-
erally recognized tribes. Linkages were conducted
using LinkPlus, a probabilistic linkage software
program developed by the CDC that was applied to
key patient identifiers.10 Possible matches, requiring
manual review, were examined independently by 2
reviewers, and when necessary, adjudicated by a
third reviewer. Information obtained from the linkage
was combined with the multiple race fields coded in
cancer registry records. If a registry record was coded
white or unknown and was identified as a positive
IHS match, the case was reclassified as AI/AN for
this analysis.8
GBC counts, incidence rates, 95% confidence
intervals, and rate ratios were calculated using
SEER*Stat Software (version 6.3.6).11 Analyses were
performed for all US counties combined meeting
quality criteria and for Contract Health Service Deliv-
ery Area (CHSDA) counties that, in general, contain
federally recognized tribal lands or are adjacent to
tribal lands.8 Analyses restricted to CHSDA counties
are presented for the purpose of offering improved
accuracy in interpreting cancer statistics for AI/AN.8
For this report, registries in 46 states and the District
of Columbia contributed data to the ‘‘All counties’’
analysis, and 33 registries contributed data to the
CHSDA county analyses.8 Approximately 56% of the
US AI/AN population reside in CHSDA counties. This
proportion varies by IHS region: Alaska: 100%; East:
15.4%; Northern Plains: 51.5%; Southern Plains:
69.0%; Pacific Coast: 45.0%; and Southwest: 88.1% (in
each region the proportion of AI/AN in CHSDA
counties to AI/AN in all counties.) Figure 1 illustrates
the states included in this analysis by CHSDA county.
Denominators for rate calculations are from the
US Census Bureau and are slightly modified by SEER
to produce potentially more accurate rates.1 All rates
are expressed per 100,000 persons, and are age-
adjusted to the 2000 US standard population by 19
age groups (<1, 1-4, 5-9 years, etc) by the direct
method.1 Rates are stratified by race (AI/AN and
non-Hispanic white [NHW]), sex, IHS region (North-
ern Plains, Alaska, Southern Plains, Pacific Coast,
East, and Southwest [Fig. 1]), and SEER Summary
Stage. SEER Summary Stage is a staging system routi-
nely used by cancer registries; in SEER Summary
Stage, a localized stage refers to cancer that is con-
Gallbladder Cancer Incidence Among AI/AN/Lemrow et al 1267
fined to the gallbladder, regional stage refers to can-
cer that has spread directly beyond the gallbladder
or to regional lymph nodes, and distant stage refers
to cancer that has spread to other organs.12 The
stage presentation is restricted to cases from 2001 to
2003 because of major differences in SEER Summary
Stage coding for cases diagnosed before 2001 and af-
ter 2003.12 Frequency calculations and rates are
shown for age analyses (<50, 50-64, and 65 1 years)
and are stratified by race and sex. Age groups were
selected with consideration of age-related influences,
such as Medicare benefits.
RESULTS
Overall, from 1999 through 2004 the GBC rate among
AI/AN in all counties of the US was 2.1 per 100,000
(Table 1). Rates varied considerably among IHS
regions. They were lowest in the East (0.5) and high-
est in Alaska (5.5). In most IHS regions, GBC rates
were higher among AI/AN females than among AI/
AN males, with the exception of the East region, in
which the GBC incidence rate was the same among
AI/AN males and females (0.5). The highest regional
rates among AI/AN males and females individually
were found in Alaska (4.6 for males and 6.9 for
females). Overall, the GBC incidence rate was signifi-
cantly higher among AI/AN (2.1) than for NHW (1.0)
(P < .05). Significantly higher rates among AI/AN
compared with NHW were also observed in all IHS
regions, with the exception of the Pacific Coast
region, where the difference was not statistically sig-
nificant. For the CHSDA county analysis, the overall
GBC incidence rate was higher, as expected, at 3.3
per 100,000. Incidence patterns similar to those in
the all-counties analysis were present in the CHSDA
county analysis. Incidence rates varied widely by
region (range, 1.5-5.5), and they were higher among
AI/AN females than among AI/AN males (with the
exception of the Northern Plains region). Finally, the
overall (3.3 for AI/AN, 0.9 for NHW; P < .05) and re-
gional AI/AN rates were significantly higher than
NHW rates for all IHS regions except the East region.
In CHSDA counties, the majority of AI/AN
(65.3%) and NHW (77.0%) were diagnosed at age
65 years (Table 2). For those aged 65 years, the
AI/AN incidence rate was significantly higher than
that for NHW (20.0 compared with 5.5; P < .05).
Approximately one-quarter (25.9%) of the diagnoses
occurred among AI/AN ages 50 years to 64 years,
and nearly one-tenth (8.8%) occurred among AI/AN
aged <50 years. These percentages were higher than
those found among NHW for the same age groups
(19.2% for ages 50 years-64 years, and 3.7% for ages
<50 years). The incidence rate for AI/AN aged 50
years to 64 years was significantly higher than that
for NHW (3.9 vs 1.2; P < .05). As with the regional
analyses, AI/AN and NHW females had higher inci-
dence rates than AI/AN and NHW males for every
age category.
GBC was diagnosed most often at regional stages
among AI/AN (36.4%) in CHSDA counties (Table 3).
Among NHW, GBC diagnoses were more often of
regional (33.3%) or distant (33.3%) stage. Slightly
higher percentages of GBC were diagnosed at a loca-
lized stage compared with NHW (27.3% vs 22.2%).
Incidence rates were higher among AI/AN than for
NHW for localized, regional, and distant stage
disease.
DISCUSSION
This study yielded several important and novel find-
ings. Consistent with other studies, significantly
higher incidence rates of GBC were found among AI/
AN than among NHW, AI/AN GBC rates were almost
always higher among AI/AN females than for AI/AN
males, and AI/AN were more often diagnosed at
younger ages than were NHW. Novel findings of this
study include the observation of considerable re-
gional variation of GBC incidence rates by IHS
region, and greater percentages of localized disease
diagnoses among AI/AN than for NHW.
The higher GBC rates noted among AI/AN in this
study and others may be explained in part by the
relation between GBC and gallstone formation. Gall-
stones contribute to the development of GBC by
causing chronic inflammation that rarely leads to
malignant transformation.2,13 It has also been sug-
FIGURE 1. States and Contract Health Service Delivery Areas (CHSDA)
counties by Indian Health Service region.
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gested that the chronic inflammation caused by gall-
stones may act as a promoter for some other carci-
nogenic exposure in GBC.2 In AI/AN, the presence of
gallstones appears to increase the risk of developing
GBC in particular for this population compared with
other racial and ethnic populations.14 In addition,
evidence suggests that AI/AN have higher rates of
gallstones than do NHW. The Strong Heart Study,
which examined gallbladder disease (defined as
ultrasound evidence of gallstones or cholecystec-
tomy) among > 3000 members of multiple AI tribes,
reported prevalence rates of 64.1% among females
and 29.5% for males.15 Similar studies have found
gallbladder disease prevalence rates to be much
lower in NHW populations (16.6% and 8.6%, respec-
tively, among females and males).16
Our findings confirm those from previous studies
that have found higher rates of GBC among females
than among males.4,5,17 Female sex and parity are
known risk factors for gallbladder disease and GBC.18
Higher rates of gallstone formation among females
may be related to the hormonal environment.
Females have a higher prevalence of gallstones and
are prone to develop biliary sludge and/or gallstones
during pregnancy.19 Compelling evidence of the asso-
ciation of parity with GBC was reported in the
SEARCH study, which concluded that females with
>3 pregnancies had more than twice the risk of
developing gallstones than did females with only 1
pregnancy.18 Although oral contraceptives have been
implicated in the carcinogenesis of GBC, a conclusive
association has not been proven.2,20 There is also
insufficient evidence for a conclusive association
with hormone replacement therapy.18,20
The variation in GBC incidence by IHS region
reported herein may be related to lifestyle and be-
havioral factors, such as obesity and tobacco use.
Recent reviews have reported an association between
obesity and GBC,13,18,21 and multiple studies have
reported higher obesity rates among AI/AN than for
other racial and ethnic populations.22–25 Current esti-
mates using the CDC’s Behavioral Risk Factor Sur-
veillance System (BRFSS) data show that AI/AN have
a higher prevalence of obesity (body mass index >30
kg/m2) than do NHW in all IHS regions, although
there was no discernable pattern by IHS region.22
Tobacco use has also been associated with
GBC.26,27 Chow et al26 reported a 50% excess risk of
biliary tract cancer, including GBC, among tobacco
users. BRFSS data demonstrate that current smoking
rates vary widely by IHS region, being highest in the
Northern Plains (40.1%) and Alaska (39.4%) and low-
est in the Southwest (21.0%).22 According to the 2004
Report of the Surgeon General on health conse-
quences of smoking, there is insufficient evidence to
allow an inference of a direct causal relation between
smoking and GBC28; therefore, tobacco may act
synergistically with other risk factors such as obesity
to increase the risk of developing GBC. Other health
behaviors that increase the risk of developing cancer,
such as low levels of physical activity, are also found
more often among AI/AN.22
AI/AN were more often diagnosed with regional
stage GBC than were NHW. As is the case with most
cancers, early diagnosis is a key factor in survival
from GBC. Treatment with surgery becomes more
difficult with regional GBC, and GBC does not
respond well to currently available systemic chemo-
therapy.2 Patients with advanced disease have a 1-
year survival rate of <5%,29 and such patients are
generally treated with palliation for relief of pain,
jaundice, and bowel obstruction.2 It is unlikely that
the increased rates of cholecystectomy explain the
increased incidence of localized GBC in AI/AN. A
study examining this correlation in a Scottish popu-
lation found that incidence of GBC was not increased
with increased cholecystectomy, nor was survival
improved, suggesting that incidental discovery
of early–stage cancer during cholescystectomy is
unlikely.30
Similar to 1 other report,6 this study found that
GBC was diagnosed in higher percentages in younger
age groups of AI/AN compared with NHW. Earlier
age of onset for GBC has also been reported in
India,31 and GBC was found to be correlated with
gallstone formation in this population. Persons with
gallstones were found to present with GBC at an age
that was 5.6 years younger than those with no gall-
stones. The authors also concluded that GBC was
associated with lower socioeconomic status inde-
pendent of gallstones. A similar association between
GBC incidence and socioeconomic status was found
in a Scottish population30; males and females living
in the most economically deprived areas of Scotland
were found to have a higher incidence of GBC. AI/
AN in the US tend to have lower socioeconomic sta-
tus than do NHW.32 Similar to smoking, lower socio-
economic status may act with other risk factors to
increase the risk of developing GBC among AI/AN
populations.
GBC is an aggressive disease that carries a poor
prognosis, and significant improvements in survival
are unlikely to be noted with currently available che-
motherapeutic agents.2 Several tumor suppressor
and oncogenes, such as p53 and K-ras, have been
shown to be mutated or overexpressed in GBC.33,34
To our knowledge, the contribution of these genetic
risk factors is currently unknown in AI/AN popula-
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tions. Future molecular biologic studies may lead to
the identification of targeted therapies for GBC. At
this time, careful preoperative imaging for all
patients undergoing gallbladder removal and appro-
priate workup for all suspicious lesions, especially for
populations at greater risk such as AI/AN, may offer
the best options for improved survival.2
Several limitations need to be considered when
interpreting the results of the current study. Although
data linkages between central cancer registry data
and IHS enrollment data reduced racial misclassifica-
tion for AI/AN living in CHSDA counties, our algo-
rithm does not correct for misclassification of those
individuals who are not members of federally recog-
nized tribes who are not in the IHS database. Many
AI/AN who live primarily in urban non-CHSDA areas
are underrepresented, and thus the findings are not
generalizable to all AI/AN in the US or in individual
IHS regions, especially those, such as the East region,
with a small overall proportion living in CHSDA
counties.
In summary, to our knowledge this is the most
comprehensive analysis of GBC incidence among AI/
AN in the US population. These findings provide a
basis for healthcare providers, cancer control plan-
ners, and community outreach professionals to begin
to address the needs of the AI/AN population regard-
ing this disease. Future efforts that ensure high-qual-
ity data availability from all population-based cancer
registries in the US, and the further development
and evaluation of methodologies to reduce AI/AN
misclassification in cancer registries, would greatly
benefit the description of GBC, as well as other can-
cers, among all AI/AN.
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